GSK plc — RNS

Regulatory news across GSK, GSK

Date	TIDM	Time	Date	TIDM	TitleTitle (filtered)	Company	Source
12/06/25	GSK	11:00:00	12 Jun 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
25/05/22	GSK	15:41:00	25 May 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
01/12/21	GSK	11:05:00	1 Dec 2021	Total Voting Rights	GSK	Total Voting Rights	GSK plc	PRN
24/07/18		10:00:03	24 Jul 2018	ViiV shows positive phIII data on two-drug combo		ViiV shows positive phIII data on two-drug combo	GlaxoSmithKline PLC	RNS
19/07/18		17:45:04	19 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/07/18		18:46:45	17 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/07/18		17:54:03	17 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/07/18		17:49:32	17 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
16/07/18		15:51:39	16 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
16/07/18		12:11:56	16 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
13/07/18		17:16:11	13 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
13/07/18		17:16:04	13 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
11/07/18		15:42:11	11 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
02/07/18		15:30:02	2 Jul 2018	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
14/06/18		08:00:04	14 Jun 2018	Positive headline results for ViiV GEMINI studies		Positive headline results for ViiV GEMINI studies	GlaxoSmithKline PLC	RNS
12/06/18		18:15:08	12 Jun 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
12/06/18		15:00:06	12 Jun 2018	GSK announces changes to Corporate Executive Team		GSK announces changes to Corporate Executive Team	GlaxoSmithKline PLC	RNS
01/06/18		14:00:01	1 Jun 2018	GSK completes Consumer Healthcare buyout		GSK completes Consumer Healthcare buyout	GlaxoSmithKline PLC	RNS
01/06/18		10:42:50	1 Jun 2018	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
29/05/18		08:00:14	29 May 2018	GSK Once-daily single inhaler triple therapy COPD		GSK Once-daily single inhaler triple therapy COPD	GlaxoSmithKline PLC	RNS
21/05/18		12:02:32	21 May 2018	ViiV granted EU marketing authorisation for Juluca		ViiV granted EU marketing authorisation for Juluca	GlaxoSmithKline PLC	RNS
15/05/18		14:39:15	15 May 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
11/05/18		16:17:08	11 May 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
10/05/18		18:20:01	10 May 2018	Block listing Interim Review		Block listing Interim Review	GlaxoSmithKline PLC	RNS
09/05/18		18:05:56	9 May 2018	Director/PDMR Shareholding - replacement		Director/PDMR Shareholding - replacement	GlaxoSmithKline PLC	RNS
03/05/18		19:31:41	3 May 2018	Result of General Meeting		Result of General Meeting	GlaxoSmithKline PLC	RNS
03/05/18		19:29:03	3 May 2018	Result of AGM		Result of AGM	GlaxoSmithKline PLC	RNS
01/05/18		15:45:04	1 May 2018	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
27/04/18		13:43:49	27 Apr 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
26/04/18		16:30:13	26 Apr 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
25/04/18		13:07:52	25 Apr 2018	Second Price Monitoring Extn		Second Price Monitoring Extn	GlaxoSmithKline PLC	RNS
25/04/18		13:02:34	25 Apr 2018	Price Monitoring Extension		Price Monitoring Extension	GlaxoSmithKline PLC	RNS
25/04/18		13:00:01	25 Apr 2018	1st Quarter Results		1st Quarter Results	GlaxoSmithKline PLC	RNS
24/04/18		18:41:04	24 Apr 2018	Trelegy Ellipta expanded US COPD indication		Trelegy Ellipta expanded US COPD indication	GlaxoSmithKline PLC	RNS
19/04/18		08:00:01	19 Apr 2018	IMPACT study shows benefits of Trelegy Ellipta		IMPACT study shows benefits of Trelegy Ellipta	GlaxoSmithKline PLC	RNS
18/04/18		11:34:49	18 Apr 2018	Landmark IMPACT study to be published in NEJM		Landmark IMPACT study to be published in NEJM	GlaxoSmithKline PLC	RNS
18/04/18		11:02:07	18 Apr 2018	IMPACT study shows benefits of Trelegy Ellipta		IMPACT study shows benefits of Trelegy Ellipta	GlaxoSmithKline PLC	RNS
17/04/18		14:47:53	17 Apr 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/04/18		14:36:07	17 Apr 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/04/18		14:30:27	17 Apr 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/04/18		14:24:34	17 Apr 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/04/18		14:20:07	17 Apr 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
13/04/18		16:50:25	13 Apr 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
13/04/18		16:44:49	13 Apr 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
13/04/18		12:32:34	13 Apr 2018	Notice of GM		Notice of GM	GlaxoSmithKline PLC	RNS
12/04/18		16:04:30	12 Apr 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
03/04/18		17:14:28	3 Apr 2018	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
29/03/18		14:00:02	29 Mar 2018	Notice of AGM		Notice of AGM	GlaxoSmithKline PLC	RNS
27/03/18		08:00:02	27 Mar 2018	GSK agrees to acquire CH business from Novartis		GSK agrees to acquire CH business from Novartis	GlaxoSmithKline PLC	RNS
23/03/18		11:21:22	23 Mar 2018	ViiV - CHMP positive opinion for Juluca in Europe		ViiV - CHMP positive opinion for Juluca in Europe	GlaxoSmithKline PLC	RNS

Showing 1501–1550 of 2,805 announcements